Skip to main navigation

Platforms
Pipeline
- Pipeline
- GoCAR-T®
Publications
- Scientific Publications
About Us
Investors & Media
Search Close

Mobile Menu Mobile Close

Platforms

Platforms
GoCAR™ Technology
CaspaCIDe® Safety Switch

Pipeline

Pipeline
GoCAR-T®

Publications

Scientific Publications

About Us

Management Team
Board of Directors
Advisory Board
Careers

Investors & Media

Investor Center
News & Events
Stock Information
Financial Information
- Annual Reports & Proxies
- SEC Filings
Corporate Governance
Investor FAQ
Contact Us

Search

Inpage Nav - News & Events

Press Releases
Events and Presentations
Email Alerts

Press Releases

Press Releases

Year

Date

Title
11/10/22

Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational Update
10/31/22

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/04/22

Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the Mesa
10/03/22

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/22

Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
08/11/22

Bellicum Reports Second Quarter 2022 Financial Results and Provides Operational Update
07/01/22

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/12/22

Bellicum Reports First Quarter 2022 Financial Results and Provides Operational Update
05/02/22

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/24/22

Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
01/26/22

Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference

Next: Events and Presentations

Platforms

Platforms
GoCAR™ Technology
CaspaCIDe® Safety Switch

Pipeline

Pipeline
GoCAR-T®

Publications

Scientific Publications

About Us

Leadership Team
Board of Directors
Advisory Board
Careers

Investors & Media

Investor Center
News & Events
Stock Information
Financial Information
Corporate Governance
Investor FAQ
Contact Us

Copyright ©2022 Bellicum Phamaceuticals, Inc. All rights reserved.

Contact Us
Privacy Policy
Terms of Use